الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 112 |  |  |
| | | from | 112 | | |
Abstract
This work aims to evaluate the early use of Clomiphene Citrate, during the luteal phase of the previous cycle for induction of ovulation for PCOS patients, compared with the its ordinary use early in the proliferative phase of induced cycle.
Conclusion:
The present study concluded that:
1- Clomiphene Citrate therapy improves menstrual pattern, ovulatory rates and pregnancy rates women with PCOS when used in the luteal phase.
2- There is a significant improvement in endometrial thickness when used in luteal phase in women with PCOS.
3- Late Clomiphene Citrate is associated with a significant reduction in the serum levels of PCOS women.